Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
1 clinical trials · Condition
◉ Watch Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
| Record | Firm | Date |
|---|---|---|
| Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma (NCT01582776) | The Lymphoma Academic Research Organisation | 2012-10-03 |
Track Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II) automatically
Every clearance here is in the API, with alerts when new ones post.